A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
NCT03696069
·
clinicaltrials.gov ↗
COMPLETED
Status
501
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
Non-Interventional
Sponsor
Bristol-Myers Squibb